Bocxman, You said: "Let's take $20 mil in revs, and 50 mil shares outstanding, and a biotech industry standard p/e of 30. That's .38 EPS, or $11.40/share!! Now let's discount back 20% for time/risk and we get $9.12/share"
when you say revenues,you mean earnings?Not clear enough.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.